Biora Therapeutics (BIOR) Projected to Post Earnings on Tuesday

Biora Therapeutics (NASDAQ:BIOR) is projected to release its earnings data after the market closes on Tuesday, March 25th. Analysts expect Biora Therapeutics to post earnings of ($3.30) per share and revenue of $0.23 million for the quarter.

Biora Therapeutics Trading Up 0.2 %

Biora Therapeutics stock opened at $0.13 on Monday. The firm has a market cap of $589,799.20, a PE ratio of -0.01 and a beta of 1.12. Biora Therapeutics has a 12 month low of $0.15 and a 12 month high of $13.30. The stock’s 50 day simple moving average is $0.15 and its two-hundred day simple moving average is $2.07.

About Biora Therapeutics

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.